Pricing Log in Create free account

LianBio Sponsored ADR (LIANY) vs Lite Strategy, Inc. (LITS)

LianBio Sponsored ADR and Lite Strategy, Inc. are both Biotechnology companies. LianBio Sponsored ADR and Lite Strategy, Inc. are of similar size ($36.3M and $34.2M). Lite Strategy, Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 9 metrics below, LianBio Sponsored ADR leads on 7 and Lite Strategy, Inc. on 2.

Valuation

Metric LIANY LITS Biotechnology median
P/E 0.02 n/m 8.50
P/S n/m 0.37 9.71
P/B 0.01 0.95 2.13
Price to free cash flow 0.02 n/m 20.82
EV/EBITDA 5.72 n/m 0.64
EV/Sales n/m 0.32 9.21
Earnings yield 5,773.40% (179.62%) (33.15%)
Free cash flow yield 4,795.89% (264.16%) (25.50%)

Profitability

Metric LIANY LITS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 70.96% (243.02%) (56.36%)
Return on assets 66.19% (233.37%) (48.04%)
Return on invested capital (450.47%) (115.85%) 0.00%

Growth

Metric LIANY LITS Biotechnology median
Revenue growth (TTM) — 152.90% 6.02%
EPS growth (last fiscal year) 75.44% 13.86% 30.26%
Revenue growth, 5-year CAGR — 67.75% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIANY LITS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.03 5.74 4.72
Net debt to EBITDA 7.41 0.09 0.96

Dividend

Metric LIANY LITS Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric LIANY LITS Biotechnology median
Market cap 34.19m 36.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack